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SUMMARY
Cancer mortality in the 35- 74 year age-range for selected sites during the
period 1979 - 88 was investigated for the 26 district council areas ofNorthern
Ireland. Trends in rates during the period were also studied and compared with
trends in an earlier period, and with trends reported from the rest of the United
Kingdom.
Statistically significant differences between the age-standardised death rates in
the26 areas were observedforstomach cancer(women only), pancreatic cancer
(women only), lung cancer (men and women) and for all cancers (men and
women). Some evidence ofspatial aggregation ofrates was apparentforovarian
cancer even though rates in the 26 areas did not differsignificantly. Thepatterns
are illustrated with maps and some difficulties of interpretation are discussed.
Mortality rates for oesophageal cancer increased during the period in both
sexes while rates for stomach cancer decreased. Colon cancer rates increased
significantly only in men, while an increase in lung cancer rates was confined to
women. The mortality from all cancers increased significantly during the period
by O 8% perannum in men and 0-9% perannum in women. These trends were
found to be broadly comparable with those reported elsewhere in the United
Kingdom.
INTRODUCTION
Approximately one fifth of all deaths in the Northern Ireland population are
attributed to cancer.1 Although for both men and women overall age.
standardised mortality rates for cancer are slightly lower in Northern Ireland
than in England and Wales, rates for colon cancer and melanoma are higher.2
Death rates throughout Britain are not uniform and recent statistics3 and cancer
atlases4'5 have highlighted prominent geographic gradients and patterns.
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This paper describes the pattern of cancer mortality among the 26 district council
areas within the province and compares the recent trends in death rates in
Northern Ireland with trends in an earlier period6 and with trends reported from
England and Wales7 and Scotland.5
MATERIAL
Mortality data were supplied on magnetic tape by the Registrar General's Office
for the period 1979 - 88. This represents the 10 year period following the intro-
ductionofthe 9threvision oftheInternational Classification ofDiseases. Although
the 9th revision introduced only minor changes in the rules for the coding of
cancer, restriction of the study to this period avoids any difficulty with cross-
revision discontinuities.
The smallest geographical unit available for deaths throughout this period wasthe
district council area. However, deaths registered since 1984 have also had the
postcode of residence coded, and this will facilitate more detailed studies of
geographical mortality variations in the future. Although the Registrar General's
Annual Report' does give tables of deaths by cause for each district council area,
these tables do not provide age-standardised comparisons.
Because of uncertainty about the registered cause of death in the elderly, only
deaths of individuals aged between 35 and 74 years have been included in the
analysis presented in this paper.
Population figures by district council area were obtained from the 1985 revision
of the 1981 census. The analysis of trends over the 10 year study period made
useoftheRegistrarGeneral's mid*year population estimates. Thevalidityofthese
estimates is supported by preliminary results from the 1991 census which
suggest that the 1990 mid-year figure overestimated the resident population at
census night by only 1-2%.
METHODS
Even with 10 years' data the numbers of cancer deaths for some sites were small,
and the analysis reported in this paper has therefore been restricted to the major
sites.
Rates in the 26 district council areas were age-standardised by the indirect
method8 using Northern Ireland rates for the entire period as the standard. This
produced standardised mortality ratios (SMR's) for each site in each district
council area which took accountofdifferences in agestructure between the areas.
An SMR of 100 indicates that an area has mortality equal to that of Northern
Ireland as a whole. Correspondingly, SMR's less than 100 and greater than 100
indicate respectively mortality lowerthan and higher than thatof Northern Ireland
as a whole. Trends in mortality were investigated by calculating directly sta'ndard-
ised rates8 using the Northern Ireland 1981 census population as the standard.
A test for heterogeneity (i.e. dissimilarityor lack ofuniformity) inthe standardised
rates among the 26 district council areas were obtained using Poisson regression
models.8 None of the causes of death considered showed evidence of extra-
Poisson variation which would have invalidated the test for heterogeneity. A test
of spatial aggregation described in a previous cancer atlas5 was employed to test
for similarity ofthe rates in adjacent district council areas. The test was applied to
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the ranks of the SMR's in the 26 areas. Fifty five pairs of district council areas
which were contiguous were identified, and a test statistic, D, was obtained as
the mean of the corresponding 55 absolute differences in ranks. The value of
D necessary for statistical significance was determined from the distribution of D
obtained in 100,000 random rankings of the 26 areas.
Trends in directly standardised rates were displayed graphically as three-year
moving averages to reduce random variation. Poisson regression models were
used to estimate and test for linear trends over the 10 year period. None of the
causes of death considered showed evidence significant of non-linear trends or
of trends which differed significantly between the age-groups under study.
RESULTS
All Cancers (ICD 140 -208)
There was highly significant heterogeneity in the mortality rates for all cancers
between the 26 areasin both men (X2 = 252
-4, df = 25; p'< 0*001) and women
(X2= 74.8, df= 25; p < 0-001). Table I shows SMR's by area for each sex.
Among both men and women the SMR was significantly elevated in Belfast and
Londonderry. The SMR's for men in Castlereagh and for women in Newry &
Mourne were also significantly elevated. Variations in mortality appeared to be
greater among men. For both sexes there was a cluster of high mortality in the
Belfast, Castlereagh, Newtownabbey and Carrickfergus areas, although the test
for spatial pattern was only significant among men (D =6-67, p < 0*01).
Trendsin mortalityforthe major sitesare depicted in Fig 1. There wasa significant
increasein mortality from all cancers during theperiod, estimated as 0*8% (95%
confidence limits 0 1% and 1.4%) per annum in men and 0-9% (0.2% and
1 -6%) per annum in women. Such a trend has been apparent in male rates since
the 1950's, but represents a more recent phenomenon in female rates.6
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Fig 1. Trends in directly standardised mortality rates per 100,000 (age 35 -74 years) for the major
cancer sites in Northern Ireland, smoothed using a three-year moving average.
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Oesophagus (ICD 150)
In neither sex was there evidence of significant heterogeneity or spatial aggreg-
ation in oesophageal cancer between the district council areas. Table 11 shows
that no individual SMR significantly exceeded 100, and most of the SMR's which
were significantly less than 100 were based on small numbers of deaths.
An increasing trend in mortality from oesophageal cancer was evident in both
sexes, although the result only attained significance in men (X2 = 4-46, df= 1;
p< 0-05). The increase was estimated as 4% per annum in both men and
women. This represents a reversal of a generally decreasing trend in rates
reported for all age-groups during the 30-year period ending in 1975.6 Recent
increases in mortality have also occurred in England and Wales7 and incidence
rates have been reported to have increased dramatically in Scotland since 1970.5
In viewofthe very poor prognosis associated with this site, it islikely that mortality
data provide a good measure of the incidence rate.
Stomach (ICD 151)
In men, district council variations in stomach cancer mortality did not attain
significance, although SMR's significantly greater than 100 were observed in
Belfast (116) and Newry & Mourne (134). However, significant heterogeneity in
rates was observed in women (X2 = 45*4, df= 25; p< 0-05). Although the
SMR for Belfast (123) was the only one significantly to exceed 100, Newry &
Mourne (140) had the highest rate. The corresponding map in Fig 2 suggests
clusters of high incidence among women in the west, east and south-east of the
Province, but the same pattern was not evident among men. The test of spatial
aggregation failed to attain significance in either sex.
In both men (X2=13-6, df=1; p< 0-001) and women (X2=10-5; df=1;
p < 0-01) there was a significant decrease in stomach cancer mortality through -
out the period. The reduction was estimated as 4% per annum in men and 5%
perannum in women. This decreasing trend isa continuation ofalong-established
pattern in stomach cancer mortality in Northern Ireland,6 and a similar decline
has taken place in England and Wales7 and in Scotland.5
Colon (ICD 153)
In neither men nor women was there evidence of significant heterogeneity in
colon cancer mortality between areas. Individual SMR's which significantly
exceeded 100 occurred among men in Craigavon (152) and among women in
Lisburn (134) and Londonderry (138). The tests for spatial aggregation did not
attain significance.
An increasing trend in colon cancer mortality was significant only among men
(X2= 7-29, df=1; p< 0-01). The increase was estimated as 3% per annum.
Historical data show a reduction in mortality among both men and women in
Northern Ireland in the 1950's followed by a steady increase in the 1960's and
1970's.6 In England and Wales the male rate has remained static in recent years
while the female rate has continued to decline.7
© The Ulster Medical Society, 1991.
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Fig 2. Map of standardised mortality ratios (age 35 - 74 years) for cancer of the stomach during the
period 1979 - 88 in 26 district council areas.
Rectum (ICD 154)
There was no evidence of variation or aggregation in rates for rectal cancer
mortality in the 26 areas. The SMR for men in Newry & Mourne (158) was the
only one significantly to exceed 100.
Trends in rectal cancer were not significant for either sex. This is in keeping with
data for the pre- 1975 period which showed little change in the rates in either
sex since the 1960's.6 In contrast, rates in England and Wales have declined
steadily in the post-war years.7
O The Ulster Medical Society, 1991.
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Pancreas (ICD 157)
Significant variations in pancreatic cancer were evident only among women
(X2=51*0, df=25; p<0-01), althoughtheSMRinLondonderry(178)wasthe
only one significantly to exceed 100. Fig 3 indicates that there were regions of
high mortality among women in the north and north-west of the province, a
pattern which was also apparent in the male rates. However, the test for spatial
aggregation did not attain significance for either sex.
There was no significant trend in pancreatic cancer in either men or women
during the period. The England and Wales figures showed a steady increase prior
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Fig 3. Map of standardised mortality ratios (age 35 - 74 years) for cancer of the pancreas during the
period 1979 - 88 in 26 district council areas.
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to 1970, but rates have stabilised in more recent years.7 Incidence rates in
Scotland were still increasing in the 1970's.5 The poor prognosis of pancreatic
cancer would suggest that the incidence rate in Northern Ireland should mirror
the mortality rate.
Trachea, bronchus, lung (ICD 162)
Lung cancer rates showed highly significant area to area variation both among
men (X2=316-7, df=25; p<0-001) and women (X2=147*0, df=25;
p < 0-001). Significantly elevated SMR's were observed among men in Belfast
(142), Castlereagh (127) and Londonderry (119). Among women, SMR's were
also significantly raised in Belfast (146) and Londonderry (127). Fig 4 illustrates
that the majority ofother areas had SMR's less than 100, and that the south-west
oftheProvince had particularlylow mortality from lung cancer. The testforspatial
aggregation was significant in men (D = 6-75, p < 0-01) but not in women.
Asignificant trend inlung cancer mortality wasevident onlyinwomen (X2 = 10- 1,
df= 1; p < 0-01). An estimate of the increase in rate was 3% per annum. In
contrast, mortality among men remained relatively static throughout the 10 year
period. Historical data for Northern Ireland indicate that male rates increased
almost tenfold while female rates trebled in the 45 year period ending in 1975.6
Male rates have recently begun to decline in England and Wales, but female rates
continue to increase.7
Breast (ICD 174)
There was no evidence of significant area to area variation or spatial aggregation
in breast cancer mortality rates, and none of the 26 areas had an SMR which
significantly exceeded 100.
The slightly increasing trend in breast cancer mortality during the period did not
attain significance. There has been an increase in rate in Northern Ireland in the
25 years to 1975,6 a trend which continues to be apparent in the England and
Wales rates.7
Ovary and other uterine adnexa (ICD 183)
Variations in ovarian cancer between areas did not attain significance, with no
SMR for any area significantly exceeding 100. However, the test of spatial
aggregation was highly significant (D =6-82, p < 0-01). The map in Fig 5 shows
an area of high incidence in the north of the province with areas of low incidence
in the west and around Belfast.
A net upward trend in mortality from ovarian cancer during the period did not
attain significance. England and Wales data showed an increase in post-war
years, but rates have stabilised recently.6 Incidence in Scotland has been
increasing for many years.5
Prostate (ICD 185)
There was no evidence of significant heterogeneity or spatial aggregation in
prostatic cancer, with no SMR showing statistically significant elevation.
( The Ulster Medical Society, 1991.
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Fig 3. Map of standardised mortality ratios (age 35 - 74 years) for cancer of the lung during the
period 1979-88 in 26 district council areas.
The upward trend in prostatic cancer mortality apparent during the period did not
attain significance. A gradual increase in rate has occurred in Northern Ireland in
the 30 years to 1975.6 England and Wales mortality rates continue to show an
increasing trend7 as do Scottish incidence rates.5
©) The Ulster Medical Society, 1991.
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Fig 5. Map of standardised mortality ratios (age 35 - 74 years) for cancer of the ovary during the
period 1979-88 in 26 district council areas.
Bladder (ICD 188)
In neither men nor women was there evidence of heterogeneity or spatial
aggregation in bladder cancer mortality in the areas. No area had an SMR
significantly exceeding 100.
There was no significant trend in bladder cancer mortality in either men or
women. Incidence rates have been rising in Scotland in both sexes.5
DISCUSSION
Regional mortality analysis is potentially useful in health planning and indeed,
since the clarification of responsibilities outlined in the recent NHS White Paper,
has been central to needs assessment undertaken by public health medicine
departments. Such analyses have limited explanatory power but may sometimes
generate new hypotheses that demand further investigation. Although some of
the patterns described in this report, such as the high lung cancer mortality in
Belfast and Londonderry, can be partly explained by the distribution of known
risk factors (eg smoking and air pollution), it is important to clarify some method -
ological issues before any apparent geographic pattern is assumed to have an
environmental origin.
Firstly, whilst age-standardisation permitscomparisons between regionsthat take
into account differences in population age-structure, many standardised indices
are heavily weighted by deaths among the elderly.9 High SMR's can be indicative
of more disease or earlier deaths (or both), and the distinction markedly affects
the choice of hypothesis that may be advanced to explain regional variations.10
Related to this is the fact that many chronic diseases such as cancer have long
induction periods, and exposures early in life (possibly even in childhood) may be
(c) The Ulster Medical Society, 1991.
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important in determining the disease distribution. For instance, although we have
observed heterogeneity in female stomach cancer mortality in Northern Ireland,
some recent evidence has suggested that the area of birth is a more important
determinant of risk for this cancer than is the area of death."1
Whilst our analysis has been based on the deceased's usual place of residence, it
should be pointed out that cross-area migration may dilute the impact of local
"exposures". Even for non -migrants the areaof "usual residence" may notalways
be correctly reported on the death certificate.12
An associated problem is that, in small areas, migration could potentially produce
significant distortions in the denominator populations used to calculate rates. It
has been estimated that only four district councils experienced greater than 10%
net migration in the five years following the 1981 census.13 Two of these, Newry
& Mourne and Londonderry, had net inward migration. High death rates in these
areas may therefore reflect underestimation of the denominator.
Nevertheless, as highlighted in a recent review of small area variations of
leukaemia mortality,14 a peculiar geographic pattern should not invoke extrinsic
causal explanations until possible confounding by intrinsic denominator
characteristics such as the social class composition or material deprivation of an
area have been taken into account. Unfortunately, any supplementary statistical
investigation which employs geographical area as the unit of analysis may fall
foul of the "ecological fallacy", whereby associations observed in aggregate data
may not reflect the true associations which exist at the level of the individual.'5
Attempts to adjust for the influence ofconfounding factors using aggregated data
from administrative areas (such as district councils) must therefore be interpreted
cautiously.
If observed geographical patterns or secular trends cannot be attributed to
distortion by small numbers, difficulty in determining the population at risk, bias
from migration, or variation in the accuracy of cause of death, then a search for
anexplanation is required. Onemust thenconsider whethertheobserved patterns
or trends are a pointer to aetiological factors or a reflection of variations in
survival. Methods exist that can help distinguish between these alternatives, but
they rely on the availability of comprehensive disease surveillance data, such as
can be provided by a cancer registry.'6
Whilst the present results taken in isolation could not be the basis of any directed
publichealthaction, thepatterns uncovered do meritfurtherstudy. Unfortunately,
in addition to its lackofcompleteness,17 the local cancer registry neither publishes
data byplaceof residence nor routinely reports survival fromthetimeofdiagnosis.
Only when such information is available for a five or ten year period will it be
possible to discern whether district council areas with high SMR's have greater
incidence of disease or have poorer survival.
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